Skip to content

About 456,000 new cases of esophageal cancer occur each year. In the United States alone, there are 17,000 new cases. Esophageal cancer is treated with an esophagectomy, which has a 90-day mortality rate as high as 19%.

Medical illustration of a transparent human torso showing the esophagus and digestive tract, including the intestines, highlighted in red. The image focuses on the upper and lower digestive system with BIOSTAGEs innovative Cellframe technology. Dark blue background.

Biostage is pioneering a new technology to regenerate the patient’s native esophagus through Cellframe Technology. Two weeks before the esophagectomy, stem cells are extract and incubated with the Cellspan implant in a bioreactor.

An illustration showcases a close-up of a medical needle, akin to Biostage innovations, inserted into skin layers, revealing visible fat tissue, blood vessels, and nerves. The needle features an opening to highlight its role in delivering or extracting substances.

This animation shows how Cellframe Technology works to regenerate esophagus tissue and muscle through stem cells as well as the Cellspan Implant process.

Diagram showing a bioreactor with a labeled component called Cellspan Implant, seamlessly integrating Biostage technology. The illustration highlights the implant inside a transparent container against a gradient background, showcasing the advanced capabilities of Cellframe innovation.

Learn more about how XVIVO is a trusted partner for start-up companies in our blog, Start-up with Style: Launch your Visuals with XVIVO.

Related Animations

TELEFLEX MICROLAPAROSCOPY PLATFORM

TELEFLEX MICROLAPAROSCOPY PLATFORM

View
MEDTRONIC SACRAL NEUROMODULATION

MEDTRONIC SACRAL NEUROMODULATION

View